CareCloud (NASDAQ:CCLD - Get Free Report) posted its quarterly earnings results on Thursday. The company reported $0.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.10 by $0.04, FiscalAI reports. CareCloud had a net margin of 6.21% and a return on equity of 27.07%. The firm had revenue of $33.73 million for the quarter, compared to analyst estimates of $33.50 million.
Here are the key takeaways from CareCloud's conference call:
- CareCloud reported record third-quarter profitability: revenue rose 9% to $33.7 million, GAAP net income increased 54% to $4.7 million, and adjusted EBITDA grew 28% to $9.9 million. Gross margin expanded 270 basis points to 50.5%.
- Management said AI and automation are improving operating efficiency: manual claim touches fell about 44% over three months, zero-touch processing reached 84%, and the RCM denial rate was below 4%. Some expense improvement also reflected lower depreciation and amortization and capitalized development costs.
- The capital restructuring is directing more earnings to common shareholders: about 89% of third-quarter net income was attributable to them, versus 55% a year earlier. CareCloud repaid its $9 million revolver draw and reduced its term loan to $34.2 million by November 2, though debt repayment remains a priority.
- CareCloud reaffirmed 2026 guidance of $128 million–$132 million in revenue, $29 million–$31 million in adjusted EBITDA, and $0.20–$0.23 in GAAP EPS, while noting seasonal effects and execution dependencies. Growth initiatives include enterprise AI development for KabaFusion and a planned subscription compliance product, but these opportunities are still developing.
CareCloud Stock Performance
Shares of NASDAQ CCLD traded up $0.14 during midday trading on Friday, hitting $2.30. The company's stock had a trading volume of 682,047 shares, compared to its average volume of 228,131. The firm has a market capitalization of $97.73 million, a price-to-earnings ratio of 17.69 and a beta of 1.57. The company has a current ratio of 1.02, a quick ratio of 1.01 and a debt-to-equity ratio of 2.20. The stock has a fifty day moving average price of $2.01 and a 200 day moving average price of $2.46. CareCloud has a one year low of $1.67 and a one year high of $3.81.
Wall Street Analyst Weigh In
CCLD has been the subject of a number of recent analyst reports. Roth Capital dropped coverage on shares of CareCloud in a report on Tuesday, September 15th. They set a "neutral" rating for the company. Prior estimates, ratings, and price targets should no longer be relied upon. Weiss Ratings upgraded shares of CareCloud from a "hold (c-)" rating to a "hold (c)" rating in a report on Monday, October 12th. Finally, Wall Street Zen raised shares of CareCloud from a "hold" rating to a "buy" rating in a research note on Saturday, August 8th. One investment analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, CareCloud currently has a consensus rating of "Moderate Buy".
Get Our Latest Stock Report on CareCloud
About CareCloud
(
Get Free Report)
CareCloud, Inc NASDAQ: CCLD provides cloud-based health care information technology and revenue cycle management services to medical practices, hospitals and other health care organizations. The company's solutions are designed to help providers manage administrative, clinical and financial operations through integrated software and technology-enabled services.
Its offerings include electronic health records, practice management, medical billing and revenue cycle management, patient engagement tools, telehealth capabilities and related health care technology services.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CareCloud, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CareCloud wasn't on the list.
While CareCloud currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.